Cargando…
Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool
PURPOSE: The SPUR (Social, Psychological, Usage and Rational) Adherence Profiling Tool is a recently developed adaptive instrument for assessing key patient-level drivers for non-adherence. This study describes the SPUR questionnaire’s finalization and psychometric evaluation. PATIENTS AND METHODS:...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112797/ https://www.ncbi.nlm.nih.gov/pubmed/35592773 http://dx.doi.org/10.2147/PPA.S354705 |
_version_ | 1784709475812245504 |
---|---|
author | de Bock, Elodie Dolgin, Kevin Kombargi, Léa Arnould, Benoit Vilcot, Tanguy Hubert, Guillaume Laporte, Marie-Eve Nabec, Lydiane Reach, Gérard |
author_facet | de Bock, Elodie Dolgin, Kevin Kombargi, Léa Arnould, Benoit Vilcot, Tanguy Hubert, Guillaume Laporte, Marie-Eve Nabec, Lydiane Reach, Gérard |
author_sort | de Bock, Elodie |
collection | PubMed |
description | PURPOSE: The SPUR (Social, Psychological, Usage and Rational) Adherence Profiling Tool is a recently developed adaptive instrument for assessing key patient-level drivers for non-adherence. This study describes the SPUR questionnaire’s finalization and psychometric evaluation. PATIENTS AND METHODS: Data were collected through an online survey among patients with type 2 diabetes included by general practitioners and diabetologists in France. The survey included four questionnaires, SPUR and three validated adherence measures: BMQ, MARS and ACCEPT. Item-level analysis and a partial credit model (PCM) were performed to refine the response option coding of SPUR items. The final item selection of SPUR was defined using a PCM and a principal component analysis (PCA). Construct validity, concurrent validity and known-groups validity were assessed on the final SPUR questionnaire. RESULTS: A total of 245 patients (55% men, mean age of 63 years) completed the survey remotely and were included in this analysis. Refining response option coding allowed a better discrimination of patients on the latent trait. After item selection, a short, an intermediate, and a long form composed the final SPUR questionnaire. The short form will be used to screen patients for risk and then the other forms will allow the collection of further information to refine the risk assessment and decide the best levers for action. Results obtained were supportive of the construct validity of the forms. Their concurrent validity was demonstrated: moderate to high significant correlations were obtained with BMQ, MARS and ACCEPT scores. Their known-groups validity were shown with a logical pattern of higher scores obtained for patients considered non-adherent and significant differences between the scores obtained for patients considered adherent versus non-adherent. CONCLUSION: SPUR is a valid tool to evaluate the risk of non-adherence of patients, allowing effective intervention by providing insights into the respective individual reasons for lack of adherence. |
format | Online Article Text |
id | pubmed-9112797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91127972022-05-18 Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool de Bock, Elodie Dolgin, Kevin Kombargi, Léa Arnould, Benoit Vilcot, Tanguy Hubert, Guillaume Laporte, Marie-Eve Nabec, Lydiane Reach, Gérard Patient Prefer Adherence Original Research PURPOSE: The SPUR (Social, Psychological, Usage and Rational) Adherence Profiling Tool is a recently developed adaptive instrument for assessing key patient-level drivers for non-adherence. This study describes the SPUR questionnaire’s finalization and psychometric evaluation. PATIENTS AND METHODS: Data were collected through an online survey among patients with type 2 diabetes included by general practitioners and diabetologists in France. The survey included four questionnaires, SPUR and three validated adherence measures: BMQ, MARS and ACCEPT. Item-level analysis and a partial credit model (PCM) were performed to refine the response option coding of SPUR items. The final item selection of SPUR was defined using a PCM and a principal component analysis (PCA). Construct validity, concurrent validity and known-groups validity were assessed on the final SPUR questionnaire. RESULTS: A total of 245 patients (55% men, mean age of 63 years) completed the survey remotely and were included in this analysis. Refining response option coding allowed a better discrimination of patients on the latent trait. After item selection, a short, an intermediate, and a long form composed the final SPUR questionnaire. The short form will be used to screen patients for risk and then the other forms will allow the collection of further information to refine the risk assessment and decide the best levers for action. Results obtained were supportive of the construct validity of the forms. Their concurrent validity was demonstrated: moderate to high significant correlations were obtained with BMQ, MARS and ACCEPT scores. Their known-groups validity were shown with a logical pattern of higher scores obtained for patients considered non-adherent and significant differences between the scores obtained for patients considered adherent versus non-adherent. CONCLUSION: SPUR is a valid tool to evaluate the risk of non-adherence of patients, allowing effective intervention by providing insights into the respective individual reasons for lack of adherence. Dove 2022-05-12 /pmc/articles/PMC9112797/ /pubmed/35592773 http://dx.doi.org/10.2147/PPA.S354705 Text en © 2022 de Bock et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research de Bock, Elodie Dolgin, Kevin Kombargi, Léa Arnould, Benoit Vilcot, Tanguy Hubert, Guillaume Laporte, Marie-Eve Nabec, Lydiane Reach, Gérard Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool |
title | Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool |
title_full | Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool |
title_fullStr | Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool |
title_full_unstemmed | Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool |
title_short | Finalization and Validation of Questionnaire and Algorithm of SPUR, a New Adherence Profiling Tool |
title_sort | finalization and validation of questionnaire and algorithm of spur, a new adherence profiling tool |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112797/ https://www.ncbi.nlm.nih.gov/pubmed/35592773 http://dx.doi.org/10.2147/PPA.S354705 |
work_keys_str_mv | AT debockelodie finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT dolginkevin finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT kombargilea finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT arnouldbenoit finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT vilcottanguy finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT hubertguillaume finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT laportemarieeve finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT nabeclydiane finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool AT reachgerard finalizationandvalidationofquestionnaireandalgorithmofspuranewadherenceprofilingtool |